Mashael Saleem Alluqmani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mashael Saleem Alluqmani has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Abdallah Ali Alahmary
College of Medicine, King Khalid University, Abha 61421, Saudi Arabia
1 shared publication - Abdullah Almazyad
King Salman bin Abdulaziz Medical City, Medina, Saudi Arabia
1 shared publication - Almuatsim Adil Al-Harrasi
College of Medicine and Health Sciences, National University of Science and Technology, Sohar 321, Oman
1 shared publication - Bader Alotaibi
King Salman bin Abdulaziz Medical City, Medina, Saudi Arabia
1 shared publication - Bassem Yousef Sheikh
Faculty of Medicine, Taibah University, Almadinah Almunawwarah, Kingdom of Saudi Arabia
1 shared publication - Dina Alnakhli
Taibah University, Medina, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 6964
Prevalence of Delayed Healthcare Presentation and Associated Factors in Patients with Predominantly Mild Traumatic Brain Injury: A Systematic Review and Meta-Analysis
Background/Objectives: Traumatic brain injury (TBI) is a global burden and a leading cause of death and disability worldwide. Delayed healthcare presentation is significantly associated with poor outcomes. This systematic review and meta-analysis aim to estimate the prevalence of delayed healthcare presentation in patients with traumatic brain injury, identify associated determinants, and synthesize evidence to inform strategies for early intervention and improved healthcare accessibility worldwide. Methods: A comprehensive electronic search was performed in PubMed and Google Scholar, including all studies published up to 1 July 2025. Eligible studies encompassed patients of any age diagnosed with mild, moderate, or severe TBI, with both the definitions of delayed presentation and TBI severity determined according to the criteria specified by each individual study. Risk of bias in the studies was assessed using the MINORS criteria for non-randomized studies and the Appraisal Tool for Cross-Sectional Studies (AXIS). All analyses were performed using OpenMeta [Analyst] software. Results: A total of 13 studies were included in the meta-analysis. The pooled analysis of 10 studies of participants presenting to healthcare after 24 h was 23.3% (95% CI 19.1–27.4%, I2 = 99.22%, p < 0.001). Across 8 studies that included participants aged 2 years or older, the pooled proportion presenting after 24 h was 18.7% (95% CI 13.8–23.6%, p < 0.001). Five studies enrolling infants younger than 2 years yielded a pooled delayed-presentation proportion of 19.8% (95% CI 14.6–25.0%, p < 0.001). However, the random-effects pooled proportion of participants who presented to healthcare within 24 h of head trauma was 78.0% (95% CI 73.7–82.2%, p < 0.001). Substantial heterogeneity was noted across all studies. Conclusions: This meta-analysis estimates the prevalence and evaluates the determinants of delayed healthcare presentation in patients with predominantly mild TBI, as moderate-to-severe injuries were substantially underrepresented in the included studies. Our results report several factors that contributed to the delayed presentation of TBI, including geographic, socioeconomic, and clinical factors. Additionally, it demonstrates the clinical characteristics of TBI involving timing, presenting symptoms, and injury mechanism.
- 8 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 6964
Open AccessPrevalence of Delayed Healthcare Presentation and Associated Factors in Patients with Predominantly Mild Traumatic Brain Injury: A Systematic Review and Meta-Analysis
Background/Objectives: Traumatic brain injury (TBI) is a global burden and a leading cause of death and disability worldwide. Delayed healthcare presentation is significantly associated with poor outcomes. This systematic review and meta-analysis aim to estimate the prevalence of delayed healthcare presentation in patients with traumatic brain injury, identify associated determinants, and synthesize evidence to inform strategies for early intervention and improved healthcare accessibility worldwide. Methods: A comprehensive electronic search was performed in PubMed and Google Scholar, including all studies published up to 1 July 2025. Eligible studies encompassed patients of any age diagnosed with mild, moderate, or severe TBI, with both the definitions of delayed presentation and TBI severity determined according to the criteria specified by each individual study. Risk of bias in the studies was assessed using the MINORS criteria for non-randomized studies and the Appraisal Tool for Cross-Sectional Studies (AXIS). All analyses were performed using OpenMeta [Analyst] software. Results: A total of 13 studies were included in the meta-analysis. The pooled analysis of 10 studies of participants presenting to healthcare after 24 h was 23.3% (95% CI 19.1–27.4%, I2 = 99.22%, p < 0.001). Across 8 studies that included participants aged 2 years or older, the pooled proportion presenting after 24 h was 18.7% (95% CI 13.8–23.6%, p < 0.001). Five studies enrolling infants younger than 2 years yielded a pooled delayed-presentation proportion of 19.8% (95% CI 14.6–25.0%, p < 0.001). However, the random-effects pooled proportion of participants who presented to healthcare within 24 h of head trauma was 78.0% (95% CI 73.7–82.2%, p < 0.001). Substantial heterogeneity was noted across all studies. Conclusions: This meta-analysis estimates the prevalence and evaluates the determinants of delayed healthcare presentation in patients with predominantly mild TBI, as moderate-to-severe injuries were substantially underrepresented in the included studies. Our results report several factors that contributed to the delayed presentation of TBI, including geographic, socioeconomic, and clinical factors. Additionally, it demonstrates the clinical characteristics of TBI involving timing, presenting symptoms, and injury mechanism.
- Open Access
- 30 May 2026
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 57 (1) , 113
Acute isolated longitudinally extensive transverse myelitis in a patient with rheumatoid arthritis: a case report
Background: Longitudinal transverse myelitis (LETM) is characterized by a spinal cord lesion that extends more than three vertebrae. While neuromyelitis optica is the predominant cause of LETM, other potential causes include inflammatory, autoimmune, infectious, neoplastic, paraneoplastic, vascular, and metabolic etiologies. Among the autoimmune etiologies, the incidence of LETM in patients with rheumatoid arthritis (RA) is extremely rare. This report presents a case of idiopathic LETM in a patient diagnosed with RA. Case presentation: A 47-year-old female with RA presented with acute left lower limb weakness and numbness for four days, accompanied by urine incontinence. Additionally, she experienced neck and back pain and loss of sensation in the lower body for two months. No recent trauma or constitutional symptoms were reported. MRI of the spine revealed a longitudinally extensive transverse myelitis. Laboratory workup did not reveal any signs of demyelinating or infectious disease. The patient’s condition significantly improved after treatment with corticosteroid pulse therapy and plasmapheresis. Conclusion: The occurrence of LETM in RA is rare. In the case presented, we could not determine whether LETM was a neurological manifestation of RA or merely a coincidental association. However, further research is necessary to clarify the relationship between RA and LETM, as well as the underlying pathogenesis.
- 30 May 2026
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 57 (1) , 113
Open AccessAcute isolated longitudinally extensive transverse myelitis in a patient with rheumatoid arthritis: a case report
Background: Longitudinal transverse myelitis (LETM) is characterized by a spinal cord lesion that extends more than three vertebrae. While neuromyelitis optica is the predominant cause of LETM, other potential causes include inflammatory, autoimmune, infectious, neoplastic, paraneoplastic, vascular, and metabolic etiologies. Among the autoimmune etiologies, the incidence of LETM in patients with rheumatoid arthritis (RA) is extremely rare. This report presents a case of idiopathic LETM in a patient diagnosed with RA. Case presentation: A 47-year-old female with RA presented with acute left lower limb weakness and numbness for four days, accompanied by urine incontinence. Additionally, she experienced neck and back pain and loss of sensation in the lower body for two months. No recent trauma or constitutional symptoms were reported. MRI of the spine revealed a longitudinally extensive transverse myelitis. Laboratory workup did not reveal any signs of demyelinating or infectious disease. The patient’s condition significantly improved after treatment with corticosteroid pulse therapy and plasmapheresis. Conclusion: The occurrence of LETM in RA is rare. In the case presented, we could not determine whether LETM was a neurological manifestation of RA or merely a coincidental association. However, further research is necessary to clarify the relationship between RA and LETM, as well as the underlying pathogenesis.